(3.143.17.128)
Users online: 4959     
Ijournet
Email id
 

Research Journal of Pharmacy and Technology
Year : 2022, Volume : 15, Issue : 12
First page : ( 5521) Last page : ( 5528)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2022.00932

3D-QSAR, E-pharmacophore and molecular docking to explore substituted sulfonamides as carbonic anhydrase inhibitors in epilepsy

Gupta Arti1,3, Lather Viney1, Vennapu Dushyanth R.2, Kumar Sandeep3, Mallikarjun B.P.4, Dhiman Neerupma1, Sharma Archana1,*

1Amity Institute of Pharmacy, Amity University, Noida-201310, India.

2KLE University College of Pharmacy, Belagavi, India.

3School of Pharmacy, Sharda University, Greater Noida, India.

4IIMT College of Pharmacy, Greater Noida.

*Corresponding Author E-mail: asharma22@amity.edu

Online Published on 06 March, 2023.

Abstract

Background

A series of aromatic sulfonamides incorporating coumarin as a lead were designed a for epilepsy target. Carbonic anhydrase is an influential target for the expansion of lead to treat epilepsy. Experimentally known carbonic anhydrase determents were identified to develop ligand based pharmacophore for anticonvulsant model. The X-ray crystallographic make-up of carbonic anhydrases with several inhibitors were utilized to develop ten energy optimized structure based (E- pharmacophore model). Pharmacophore matched candidates were utilized for docking to reclaim hits with scaffolds. The molecules having diverse structures, high docking score and low binding energy for various crystal structures of carbonic anhydrase were selected as final hits (leads). DFT is utilized to get electronic features of hits. The docking study of ligands by discovery studio had helped to establish binding interactions. The known carbonic anhydrase was reused for the development of pharmacophore hypothesis DHHRR. Based on Insilco process we came across structurally diverse hits as noncompetitive carbonic anhydrase inhibitors with better ADME. The best three hits 4, 6 and 17 were nontoxic and were selective carbonic anhydrase inhibitors with the IC50 values respectively (IC502.01, 2.59, 2.469). The study describes that the combined pharmacophore appeal to identify various hits which have good binding affinity for the active site of enzyme in all feasible bioactive conformations.

Top

Keywords

Sulfonamides, Coumarin, 3D- QSAR, E-Pharmacophore, Epilepsy and Central Nervous System. (ESI- Electronic supporting Information).

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
740,614,630 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.